REFERENCES
- Bane A., Rojas D., Indermaur K., Bennett T., Avery D. Adverse effects of dextromethorphan on the spatial learning of rats in the Morris water maze. European Journal of Pharmacology. 1996; 302: 7–12, [PUBMED], [INFOTRIEVE], [CSA]
- Bem J. L., Peck R. Dextromethorphan. An overview of safety issues. Drug Safety 1992; 7: 190–199, [PUBMED], [INFOTRIEVE], [CSA]
- Butelman E. R. A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task. Pharmacology Biochemistry & Behavior 1989; 34: 13–16, [CSA], [CROSSREF]
- Chase T. N., Oh J. D., Konitsiotis S. Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms. Journal of Neurology 2000; 247(Suppl 2)1136–1142, [CSA]
- Darboe M. N., Keenan G. R., Jr., Richards T. K. The abuse of dextromethorphan-based cough syrup: A pilot study of the community of Waynesboro, Pennsylvania. Adolescence 1996; 31: 633–644, [PUBMED], [INFOTRIEVE], [CSA]
- Dingledine R., Borges K., Bowie D., Traynelis S. F. The glutamate receptor ion channels. Pharamcological Reviews 1999; 51: 7–61, [CSA]
- Fisher K., Coderre T. J., Hagen N. A. Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. Journal of Pain Symptom Management 2000; 20: 358–373, [CSA], [CROSSREF]
- Gorter J. A., de Bruin J. P. C. Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat. Brain Research 1992; 580: 12–17, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Holtzman S. G. Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey. Psychopharmacology 1982; 77: 295–300, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jahng J. W., Zhang T. Y., Lee S., Kim D. G. Effects of dextromethorphan on the nocturnal behavior and brain c-Fos expressions in adolescent rats. European Journal of Pharmacology 2001; 431: 47–52, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McEwen B. Estrogen actions throughout the brain. Recent Progress in Hormonal Research 2002; 57: 357–384, [CSA], [CROSSREF]
- Murray S., Brewerton T. Abuse of over-the-counter dextromethorphan by teenagers. Southern Medical Journal 1993; 86: 1151–1153, [PUBMED], [INFOTRIEVE], [CSA]
- Noonan W. C., Miller W. R., Feeney D. M. Dextromethorphan abuse among youth. Archives of Family Medicine 2000; 9: 791–792, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Price D. D., Mao J., Lu J., Caruso F. S., Frenk H., Mayer D. J. Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats. Pain 1996; 68: 119–127, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Price L. H., Lebel J. Dextromethorphan-induced psychosis. American Journal of Psychiatry 2000; 157: 304, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sagratella S. NMDA antagonists: Antiepileptic-neuroprotective drugs with diversified neuropharmacological profiles. Pharmacological Research 1995; 32: 1–13, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sircar R. Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-D-aspartate receptor upregulation. International Journal of Developmental Neuroscience 2003; 21: 159–167, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Steinberg G. K., Kunis D., DeLaPaz R., Poljak A. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan has a favourable dose response profile. Neurological Research 1993; 15: 174–80, [PUBMED], [INFOTRIEVE], [CSA]
- Venable N., Kelly P. H. Effects of NMDA antagonists on memory processes in a novel two-trial swimming test. Behavioral Pharmacology 1991; 2: 161–169, [CSA]
- Weinbroum A. A., Rudick V., Paret G., Ben-Abraham R. The role of dextromethorphan in pain control. Canadian Journal of Anaesthesia. 2000; 47: 585–596, [PUBMED], [INFOTRIEVE], [CSA]
- Willets J., Balster R. L., Leander J. D. The behavioral pharmacology of NMDA receptor antagonists. Trends in Pharmacological Sciences. 1990; 11: 423–428, [CSA], [CROSSREF]
- Wolfe T. R., Caravati E. M. Massive dextromethorphan ingestion and abuse. American Journal of Emergency Medicine. 1995; 13: 174–176, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ylinen A., Pitkanen M., Sirvio J., Hartikainen T., Sivenius J., Koivisto E., Riekkinen P. J., Jr. The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task. European Journal of Pharmacology 1995; 274: 159–165, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang T. Y., Jahng J. W., Kim E. J., Chung H., Kim D. G. Chronic dextromethorphan increases NMDAR1 immunoreactivity in the brain and induces sensitization of stereotyped behavior in female rats. Society for Neuroscience Abstract 1999; 25: 2077, [CSA]
- Zhang T. Y., Jahng J. W., Kim D. G. Dextromethorphan increases tyrosine hydroxylase mRNA in the mesencephalon of adolescent rats. Neuroscience Letters 2001; 309: 85–88, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]